(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
-2.26% INR 123.15
Live Chart Being Loaded With Signals
Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India...
Stats | |
---|---|
Tagesvolumen | 75 916.00 |
Durchschnittsvolumen | 120 109 |
Marktkapitalisierung | 4.08B |
EPS | INR0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-20 |
Last Dividend | INR2.50 ( 1996-08-12 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -100.12 |
ATR14 | INR0.321 (0.26%) |
Volumen Korrelation
Lyka Labs Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Lyka Labs Limited Korrelation - Währung/Rohstoff
Lyka Labs Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR930.73M |
Bruttogewinn: | INR555.18M (59.65 %) |
EPS: | INR-4.57 |
FY | 2022 |
Umsatz: | INR930.73M |
Bruttogewinn: | INR555.18M (59.65 %) |
EPS: | INR-4.57 |
FY | 2022 |
Umsatz: | INR1.84B |
Bruttogewinn: | INR1.30B (70.97 %) |
EPS: | INR13.57 |
FY | 2021 |
Umsatz: | INR671.07M |
Bruttogewinn: | INR291.40M (43.42 %) |
EPS: | INR-4.07 |
Financial Reports:
No articles found.
Lyka Labs Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR2.50 | 1995-09-11 |
Last Dividend | INR2.50 | 1996-08-12 |
Next Dividend | INR0 | N/A |
Payout Date | 1996-10-01 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR5.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.84 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 2.22 | |
Div. Directional Score | 1.072 | -- |
Year | Amount | Yield |
---|---|---|
1995 | INR0 | 0.00% |
1996 | INR0 | 0.00% |
1997 | INR0 | 0.00% |
1998 | INR0 | 0.00% |
1999 | INR0 | 0.00% |
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TINPLATE.NS | Dividend Junior | 2023-08-11 | Annually | 19 | 0.72% | |
PDMJEPAPER.NS | Dividend Junior | 2023-08-03 | Annually | 9 | 0.65% | |
J&KBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 22 | 0.47% | |
DATAMATICS.NS | Dividend Junior | 2023-09-22 | Annually | 21 | 0.49% | |
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MAXHEALTH.NS | Dividend Junior | 2023-09-08 | Insufficient data to determine frequency | 2 | 0.07% | |
GSPL.NS | Dividend Junior | 2023-09-01 | Annually | 19 | 0.81% | |
BANKINDIA.NS | Dividend Junior | 2023-06-20 | Sporadic | 23 | 1.34% | |
PRAJIND.NS | Dividend Junior | 2023-07-19 | Annually | 22 | 0.83% | |
KABRAEXTRU.NS | Dividend Junior | 2023-07-13 | Annually | 23 | 0.83% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0336 | 1.500 | -0.672 | -1.007 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.125 | 1.500 | -2.50 | -3.75 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0.735 | 1.000 | -0.839 | -0.839 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.01 | 2.00 | 7.33 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.01 | 2.00 | 6.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.614 | 1.000 | 3.11 | 3.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0464 | 1.000 | -1.072 | -1.072 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.0770 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -114.85 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.125 | 2.50 | -1.606 | -3.75 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.01 | 2.00 | 7.33 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.01 | 2.00 | 7.33 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.860 | 1.500 | 7.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.251 | 1.000 | 6.23 | 0 | [0.1 - 0.5] |
Total Score | 2.22 |
Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. The company offers its products in various formulations, including injections, creams, ointments, gels, and lotions. It also exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.